300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Puerto Rico
Oman
Poland
Cameroon
Guernsey
Andorra
Colombia
Sudan
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Seychelles
Moldova
Botswana
Paraguay
Japan
Ireland
Canada
United Kingdom
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Newbury Ventures, VC Fund

Newbury Ventures

VC Fund

Menlo Park, United States

Newbury Ventures is a collegial partnership based in Silicon Valley with roots from across the globe, most notably the US, Canada, Europe and the Middle East. We fund exceptional entrepreneurs, and help carry the founders' vision from creation to realization. Since the early 80s, we have financed 150+ successful ventures that grew to generatein excess of $180 billion in combined shareholders’ value.We deploy early stage capital across diversified market sectors and evolve our strategic focus in a constant dialog with the market. We invest in industry verticals, but take an interdisciplinary view of a company's ultimate potential. We seek to team with visionary companies breaking barriers and creating new markets, especially those leveraging advancements in cloud computing, big data, mobile, and social media. We are stage agnostic, but single-mindedly focused on character, commitments and results.

Total investments:
25
Last investment:
Lead investor:
36%

Last updated:

Industries Newbury Ventures invests in

Enterprise SoftwareSoftwareSemiconductorInformation TechnologyHealth Care

Stages Newbury Ventures invests in

Series BSeries CFunding RoundSeries ASeries D

Countries Newbury Ventures invests in

United StatesCanadaFranceIsraelSwitzerland

Round sizes

Series B $5M–$18MSeries C $8M–$54M

Contacts

NameEmailPhoneSocials

Sign up to unlock verified contacts

Unlock Contacts

Round size

Series B
$5M–$18M
Series C
$8M–$54M

Investment Focus

Industry

  • Enterprise Software 8 (32%)
  • Software 6 (24%)
  • Semiconductor 4 (16%)
  • Information Technology 4 (16%)
  • Health Care 3 (12%)
See all 36 industries →

Stage

  • Series B 8 (32%)
  • Series C 4 (16%)
  • Funding Round 4 (16%)
  • Series A 3 (12%)
  • Series D 2 (8%)
See all 7 stages →

Country

  • United States 12 (48%)
  • Canada 2 (8%)
  • France 1 (4%)
  • Israel 1 (4%)
  • Switzerland 1 (4%)

Team

NameTitleInvestmentsLinksEmail
Conrad Lewis
Conrad Lewis Venture Partners
Venture Partners Total investments: 0 Find email
Ossama Hassanein
Ossama Hassanein Senior Managing Director
Senior Managing Director Total investments: 2
Find email
Tamer Hassanein
Tamer Hassanein Partner
Partner Total investments: 2
Find email

Investments

CompanyDescriptionRoundLinks
NextBio is privately owned software company that provides a platform for life science researchers to search, discover, and share knowledge across public and proprietary data.Nextbio was co-founded by Saeid Akhtari, Ilya Kupershmidt and Mostafa Ronaghi in 2004 and based in Cupertino California, USA.The NextBio Platform is an ontology-basedsemantic framework that connects highly heterogeneous data and textual information. The semantic framework is based on gene, tissue, disease and compound ontologies. This framework contains information from diverse organisms, platforms, data types and research areas is integrated into and correlated within a single searchable environment using proprietary algorithms. It provides a unified interface for researchers to formulate and test new hypotheses across vast collections of experimental data. The enterprise version of the NextBio platform is being used in life science R&D and drug development by researchers and clinicians at: Merck Pharmaceutical, Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Celgene, Genzyme, Eli Lilly and Company, and [[Regeneron Pharmaceuticals. This enterprise version allows internal, proprietary data to be uploaded and integrated into the NextBio database of publicly-available data. Scientists are using NextBio to improve their ability to identify relevant prognostic and predictive molecular signatures which are significant in their research.NextBio was a receiver of the Frost & Sullivan North American Life Sciences Customer Value Enhancement Award in 2008. Since the release it has had more than 1,500,000 visitors. $8M / Series C / Sep 18, 2009
BDNA transforms enterprise asset data by enriching it with market context to vastly simplify integrations, accelerate business transformation and improve decision-making. Leveraging Technopedia®, the most trusted and comprehensive hardware and software asset information source, BDNA leverages automation, a team of content experts and a provenquality framework to reconcile and normalize enterprise asset data to improve all processes and projects.Technopedia’s content library categorizes more than 2 million products from 34,000 suppliers with 2,500 daily updates, providing business-critical information such as compatibility, support dates, end-of life, migration data, current manufacturer and version, and much more. Eliminating manual processes and bottlenecks, BDNA delivers automated and scalable solutions, improving visibility, compliance and time to market.Based in Mountain View, Calif., BDNA operates globally with customers across all segments and markets. For more information, please visit www.bdna.com. $20M / Series D / Oct 31, 2007
NextBio is privately owned software company that provides a platform for life science researchers to search, discover, and share knowledge across public and proprietary data.Nextbio was co-founded by Saeid Akhtari, Ilya Kupershmidt and Mostafa Ronaghi in 2004 and based in Cupertino California, USA.The NextBio Platform is an ontology-basedsemantic framework that connects highly heterogeneous data and textual information. The semantic framework is based on gene, tissue, disease and compound ontologies. This framework contains information from diverse organisms, platforms, data types and research areas is integrated into and correlated within a single searchable environment using proprietary algorithms. It provides a unified interface for researchers to formulate and test new hypotheses across vast collections of experimental data. The enterprise version of the NextBio platform is being used in life science R&D and drug development by researchers and clinicians at: Merck Pharmaceutical, Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Celgene, Genzyme, Eli Lilly and Company, and [[Regeneron Pharmaceuticals. This enterprise version allows internal, proprietary data to be uploaded and integrated into the NextBio database of publicly-available data. Scientists are using NextBio to improve their ability to identify relevant prognostic and predictive molecular signatures which are significant in their research.NextBio was a receiver of the Frost & Sullivan North American Life Sciences Customer Value Enhancement Award in 2008. Since the release it has had more than 1,500,000 visitors. $7M / Series B / Jun 06, 2007
Andigilog, Inc., a fabless analog and mixed-signal semiconductor company, provides intelligent thermal management solutions. Its products include sensor interface integrated circuits, temperature sensors, system controllers, and brushless DC fan motor controllers. The company’s products are used in personal computers, servers, cell phones, andconsumer electronics, as well as in automotive, industrial, biomedical, and security systems. It serves customers in the computing, cellular, consumer, and industrial electronics markets. The company offers its products through a sales network. Andigilog, Inc. was founded in 1996 and is headquartered in Tempe, Arizona. $18M / Series B / Feb 20, 2007
HydroCision develops, manufactures, and markets fluidjet based surgical tools for minimally invasive spine surgery requirements. Its products include SpineJet HydroSurgery System that is used to ablate, cut, and remove targeted tissue for spinal procedures, Spinejet, water-based technology solutions for minimally invasive spine surgeryrequirements, SpineJet HydroDiscectomy Systems, which are used to remove tissue without the risk of thermal energy for minimally invasive discectomy procedures, and AlloJet, systems to prepare bone allografts. The company also provides customer care services. HydroCision, Inc. was formerly known as Surgijet Corporation and changed its name to HydroCision, Inc. in November 1996. The company was founded in 1994 and is headquartered in North Billerica, Massachusetts. $12.7M / Series G / Jan 09, 2007
Spotwave provides carrier-approved, indoor wireless coverage solutions; giving you reliable, "always-on" wireless coverage indoors. They offer wireless carriers and enterprise customers a simple, affordable, effective way to ensure wireless devices have great coverage indoors, where they are used the most. The benefits of Spotwave'sproducts for both their enterprise and business customers, and for carriers are clear. $10M / Jan 17, 2006
MetaLINCS was founded to address the growing problem of intelligently finding important information within email repositories. Email has become the cornerstone of business communications and organizations. The automatic capture of email communication in messaging systems creates a natural record of critical messages, context of important decisionsand inherent communication patterns. Consequently, organizations are spending billions of dollars on email analysis, often as part of an investigatory discovery process or EDiscovery. Current technologies and traditional methods do not leverage the unique qualities of electronic messaging and hence do not adequately address this issue. The application of single techniques such as keyword search, knowledge management, databases or natural language processing are not sufficient. What is required is an intelligent combination of multiple technologies. $8.8M / Series A / Jul 11, 2005
Founded in 2000, Echovox has built a unique gateway infrastructure offering premium SMS, Bulk and WAP billing in more than 20 different countries, connecting more than 100 mobile carriers worldwide and covering over 500 million subscribers.As an established leader in the mobile monetization space, Echovox enables large media companies, leadingweb players, mobile content providers and application developers to monetize their traffic though mobile transactions. Echovox was venture-backed by Advent Venture Partners and Newbury Ventures and launched Zong, world’s leading mobile payment solution, sold to Paypal in 2011.Strong of a 15 year experience in the mobile payment industry, our platform ECHONECTTM provides the best unified interface to the mobile world. $5M / Series A / Jul 01, 2005
As of April 4, 2008, Meriton Networks, Inc. was acquired by Xtera Communications, Inc. Meriton Networks, Inc. offers optical networking products. Its products include carrier ethernet transport, an architecture based on wavelength networking; 3300 OSM, an optical services multiplexer; 6400 OTP, an optical transport platform; 5400 OTP, an opticaltransport platform, which provides a multi-service transport solution for network applications that do not require the high drop capacity of the full-featured 6400 OTP; 7200 OSP, an optical switching platform used for consolidating optical transport capabilities within a single network element; and 9500 NPT, a network planning tool that helps in the design and planning of optical networks. The company also offers network management software, amplifiers, and accessories. It also offers technical assistance, hardware replacement, implementation, network health check, training, and network optimization services. The company's products are used in research and education, as well as by telecom service providers, cable operators, and enterprises. It has operations in Canada, the United States, Europe, the Asia Pacific, and Central/Latin America. Meriton Networks, Inc. was formerly known as Edgeflow, Inc. and changed its name to Meriton Networks, Inc. in November 2001. Meriton Networks, Inc. was founded in 2000 and is based in Ottawa, Canada. $54M / Series C / Jun 27, 2005
Pixim is a hardware company that builds chips for video cameras.Pixim's Digital Pixel System® technology revolutionizes the way video cameras capture and process images. Unlike traditional cameras, where each pixel cannot adjust to highlights and lowlights in the same scene, Pixim's patented Digital Pixel System® technology empowershundreds of thousands of pixels to act like individual cameras constantly self-adjusting. This all-digital system enables Pixim-powered cameras to efficiently capture the whole picture, regardless of lighting condition or application – thus securing the highest resolution, natural color and clarity, while automatically eliminating image-compromising visual noise (e.g., glare, reflections). The result is more than superb image quality; it is accurate, actionable information that gives users the strength of certainty. $12M / Jun 09, 2005
See all 25 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Puerto Rico
Oman
Poland
Cameroon
Guernsey
Andorra
Colombia
Sudan
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Seychelles
Moldova
Botswana
Paraguay
Japan
Ireland
Canada
United Kingdom
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Newbury Ventures invest in?

Newbury Ventures invests primarily in Enterprise Software, Software and Semiconductor startups, most often at Series B and Series C stage. Most of the 25 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is Newbury Ventures's check size?

Newbury Ventures typically joins rounds of $5M–$18M at Series B and $8M–$54M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Newbury Ventures participates in.

How do I contact Newbury Ventures?

Public channels for Newbury Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Newbury Ventures?

The team at Newbury Ventures includes Conrad Lewis (Venture Partners), Ossama Hassanein (Senior Managing Director) and Tamer Hassanein (Partner). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Newbury Ventures Newbury Ventures Find emails